Henry Ford Health

Henry Ford Health Scholarly Commons
Internal Medicine Articles

Internal Medicine

1-1-2021

Response
Yervant Ichkhanian
Henry Ford Health, yichkha1@hfhs.org

Juliana Yang
Mouen A. Khashab

Follow this and additional works at: https://scholarlycommons.henryford.com/internalmedicine_articles

Recommended Citation
Ichkhanian Y, Yang J, and Khashab MA. Response. Gastrointest Endosc 2021; 93(1):279-280.

This Article is brought to you for free and open access by the Internal Medicine at Henry Ford Health Scholarly
Commons. It has been accepted for inclusion in Internal Medicine Articles by an authorized administrator of Henry
Ford Health Scholarly Commons.

Letters to the Editor

EUS-guided enteroenteral bypass for
transenteric ERCP: building on prior
knowledge

4. Mutignani M, Forti E, Larghi A, et al. Endoscopic entero-enteral bypass:
an effective new approach to the treatment of postsurgical complications of hepaticojejunostomy. Endoscopy 2019;51:1146-50.
https://doi.org/10.1016/j.gie.2020.07.046

To the Editor:

Response:
1

We read with interest the article from Ichkhanian et al.
On the basis of our experience, we fully agree that EUSguided enteroenteral anastomosis is a safe and effective
technique to gain access to the biliary tree and perform
ERCP in patients with surgically altered anatomy. Indeed,
the present article is not the ﬁrst report of such a procedure. In 2014, Perez-Miranda et al2 reported the ﬁrst
EUS-guided transenteric anastomosis performed to treat
a recurrent biliary malignancy in altered anatomy.
Similarly, the same technique was described by our group
to treat a benign biliary stricture after Roux-en-Y reconstruction.3 Then, in April 2019, a wider series reported the
same procedure on 32 patients, after Whipple
pancreaticoduodenectomy or other surgery with Roux-enY reconstruction.4 Successful placement of enteroenteric
lumen-apposing metal stents was achieved in 31 of 32 patients (96%.9), and in all of them ERCP was performed.
In conclusion, the present study conﬁrms EUS-guided
enteroenteral bypass as a valuable option to perform
ERCP in patients with surgically altered anatomy, especially, as the authors stated, when multiple procedures
are needed. The current article builds on several years of
previously published work and emphasizes the growing
role of this procedure.
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We appreciate the interest of Mutignani et al1 in our
article on EUS-directed transenteric ERCP (EDEE) for the
management of pancreatobiliary disease in patients with
non–Roux-en-Y gastric bypass surgical anatomy.2
In our case series, we highlighted the experience of 7
international tertiary care centers on performing de novo
enteroenteral anastomosis using a lumen-apposing metal
stent (LAMS) for the management of pancreatobiliary
(PB) diseases in patients with non-RYGB surgically altered
anatomy. Mutignani et al1 appropriately highlighted the
promising outcomes of EDEE for the management of
pancreatobiliary diseases, particularly in cases where
multiple interventions are anticipated.
EDEE is a technically challenging procedure, and an
essential step is the identiﬁcation of the afferent or the
target limb in the setting of complex altered anatomy. In
the case series reported by Mutignani et al3 in April 2019,
a percutaneous transhepatic biliary drainage (PTBD)
catheter was used to opacify and distend the afferent limb
in the majority of cases. This was followed by transluminal
advancement and deployment of a biﬂanged fully covered
self-expandable metal stent. For patients who have initially
undergone percutaneous biliary decompression, the PTBD
catheter can be used to inject saline/contrast solution to
distend the afferent limb and facilitate subsequent EDEE.
We propose that PTBD for the sole purpose of facilitating EDEE can often be avoided. We have previously
described the “direct EUS puncture” technique for identifying and opacifying the afferent limb as opposed to using
other techniques such as PTBD.4 In the direct technique,
the afferent limb is identiﬁed by EUS by following the
hepatic duct insertion into the small bowel. This small
bowel loop is punctured with a 19-gauge needle, and saline/contrast solution is injected. Filling of the afferent
limb (and possibly opaciﬁcation of the biliary tree) conﬁrms accessing the correct limb. This is then followed
directly with the advancement of a cautery-tipped lumenapposing metal stent. In our study, the majority (15/18)
of patients underwent EDEE by the direct technique, and
none required PTBD before EDEE. We believe this decreases the overall invasiveness of this approach and diminishes the number of procedures required.
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EMR, and was the result of pathologic analysis of the
biopsy specimen consistent with the postoperative
pathologic changes?
Second, we noticed that >10% of macroscopically complete resections by e-EMR did not achieve R0 resection histologically. Additional treatments such as thermal ablation
and hot avulsion were required.5 In this cohort study, eEMR was chosen for the cases of suspected submucosal
invasion. On Supplementary Table 1, surgical
histopathologic analysis conﬁrmed more residual cancer
after successful index e-EMR versus p-EMR. Instead of
simple size matching, tumor type and invasion risk
should be discussed and analyzed by propensity score
matching to reduce the conclusion bias.
Third, Burgess et al6 reported that deep mural injury
during EMR was associated with lesion size and
signiﬁcant submucosal ﬁbrosis. Fibrosis may indicate
potential invasion or lymphovascular involvement,
especially in the nongranular pseudodepressed type and
nodular mixed type.7 Subtype analysis of LSTs should be
suggested. For p-EMR, Terasaki et al2 concluded that the
local recurrence rate was signiﬁcantly higher for lesions
that were resected in 3 pieces in comparison with
lesions resected in 2 pieces or en bloc. It would be
helpful to list the number of pieces resected by p-EMR
and to make a subgroup analysis.
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Concerns of en bloc resection on
long-term outcomes after EMR for
colorectal laterally spreading tumor
To the Editor:
Recently, Tate et al1 reported in a size-matched cohort
study that en bloc EMR e-EMR offered no long-term advantage for predicted benign colonic laterally spreading
lesions 25 mm but was associated with an increased
risk of major deep mural injury. We read the report with
interest and would like to raise several concerns. We would
appreciate the authors’ clariﬁcation of some details.
First, complete en bloc resection of laterally spreading
tumors (LSTs), especially for lesions >20 mm, is generally
difﬁcult by simple EMR; piecemeal endoscopic mucosal
resection (p-EMR) and endoscopic submucosal dissection
(ESD) are often introduced.2 It is very important to do
a preoperative assessment and determine the indication
for EMR. Although the diagnostic accuracy of pit pattern
reaches 83%, a preceding biopsy can provide clearer
pathologic results without increasing the rates of
incomplete tumor resection and adverse events.3,4 Did
the patients in the study undergo forceps biopsies before
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